Metraipolis › archive › dc_e405c554e065
Combination therapy of sutimlimab and rituximab can lead to stable remission in autoimmune hemolytic anemia: a case series — Europe PMC PMID:42616150
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42616150
- DOI
- 10.1007/s00277-[numero omesso]-6
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T03:26:19.500Z
- SHA-256 of the archived text
8f77b50dc91f45cc19cba660bcdf5e44ac8af6affaa656492b4315441f37b8fb- Stable URL of this page
https://metraipolis.com/documento/dc_e405c554e065
How to cite
Combination therapy of sutimlimab and rituximab can lead to stable remission in autoimmune hemolytic anemia: a case series — Europe PMC PMID:42616150 — Europe PMC (en), https://europepmc.org/article/MED/42616150 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e405c554e065 (Metraipolis archive dc_e405c554e065, sha256 8f77b50dc91f45cc19cba660bcdf5e44ac8af6affaa656492b4315441f37b8fb)
BibTeX
@misc{dce405c554e065,
title = {Combination therapy of sutimlimab and rituximab can lead to stable remission in autoimmune hemolytic anemia: a case series — Europe PMC PMID:42616150},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42616150},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e405c554e065; sha256 8f77b50dc91f45cc19cba660bcdf5e44ac8af6affaa656492b4315441f37b8fb},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42616150. Agents can read the archived copy with the MCP tool read_document.